Literature DB >> 6230414

Isotype specificity of helper T cell clones. Peyer's patch Th cells preferentially collaborate with mature IgA B cells for IgA responses.

H Kiyono, M D Cooper, J F Kearney, L M Mosteller, S M Michalek, W J Koopman, J R McGhee.   

Abstract

The nature of the IgA B cell precursors that receive preferential help from selected clones of T helper cells from mouse Peyer's patches (PP Th A) were studied. Activation of the PP Th A clones required the presence of antigen, sheep erythrocytes (SRBC), in a culture system supporting development of antibody-secreting plasma cells. Two types of PP Th A cells were used. Both gave vigorous IgA responses; the first also supported low IgM, and the second low IgM and IgG subclass antibody responses. Removal of sIgA+ B cells from either splenic or PP B cell cultures selectively depleted precursors of IgA antibody producers. Cultures of purified sIgA+ B cells, cloned PP Th A cells and SRBC, selectively yielded IgA antibody producers. Finally, PP Th A cells did not support IgA responses in B cell cultures derived from spleens of young mice (days 1-25), and full IgA responses were not seen until the donor mice were 6-7 wk of age. These results suggest that cloned T helper cells can recognize and collaborate with mature, IgA committed B cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230414      PMCID: PMC2187251          DOI: 10.1084/jem.159.3.798

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  54 in total

1.  The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation.

Authors:  N A Mitchison
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

Review 2.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

3.  Immune responses in vitro. IV. Suppression of primary M, G, and A plaque-forming cell responses in mouse spleen cell cultures by class-specific antibody to mouse immunoglobulins.

Authors:  C W Pierce; S M Solliday; R Asofsky
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

4.  A two-stage model for development of antibody-producing cells.

Authors:  M D Cooper; A R Lawton; P W Kincade
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

5.  T cell-dependent activation of resting B cells: requirement for both nonspecific unrestricted and antigen-specific Ia-restricted soluble factors.

Authors:  J Anderson; F Melchers
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

Review 6.  Interleukin-2 dependent culture of cytolytic T cell lines.

Authors:  S Gillis; J Watson
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

7.  Candidate for immunoglobulin D present on murine B lymphocytes.

Authors:  E R Abney; R M Parkhouse
Journal:  Nature       Date:  1974-12-13       Impact factor: 49.962

8.  Suppression of immunoglobulin class synthesis in mice. I. Effects of treatment with antibody to -chain.

Authors:  A R Lawton; R Asofsky; M B Hylton; M D Cooper
Journal:  J Exp Med       Date:  1972-02-01       Impact factor: 14.307

9.  Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes.

Authors:  A S Rosenthal; E M Shevach
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

10.  Cell interactions between histoincompatible T and B lymphocytes. II. Failure of physiologic cooperative interactions between T and B lymphocytes from allogeneic donor strains in humoral response to hapten-protein conjugates.

Authors:  D H Katz; T Hamaoka; B Benacerraf
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

View more
  32 in total

Review 1.  Regulation of IgE synthesis. Lymphocyte Fc epsilon receptor, IgE binding factor(s), and glycosylation-modulating factors.

Authors:  J Yodoi; T Kawabe; M Takami
Journal:  Clin Rev Allergy       Date:  1989

2.  The induction and migration of antigen-specific helper cells for IgA responses in the intestine.

Authors:  M L Dunkley; A J Husband
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

3.  Immune-enhancing diet and cytokine expression during chronic sepsis: an immune-enhancing diet containing L-arginine, fish oil, and RNA fragments promotes intestinal cytokine expression during chronic sepsis in rats.

Authors:  Ryan T Hurt; Paul J Matheson; Michael P Mays; R Neal Garrison
Journal:  J Gastrointest Surg       Date:  2006-01       Impact factor: 3.452

Review 4.  Immunopathology of human immunodeficiency virus infection in the gastrointestinal tract.

Authors:  T Schneider; R Ullrich; M Zeitz
Journal:  Springer Semin Immunopathol       Date:  1997

Review 5.  Regulation of IgA synthesis and immune response by T cells and interleukins.

Authors:  J R McGhee; J Mestecky; C O Elson; H Kiyono
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

Review 6.  The intestinal immune system.

Authors:  W F Doe
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

Review 7.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

8.  T-cell control of IgA production. I. Distribution, activation conditions and culture of isotype-specific regulatory helper cells.

Authors:  D Campbell; B M Vose
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

9.  Isotype commitment of B cells and dissemination of the primed state after mucosal stimulation with Mycoplasma pulmonis.

Authors:  F V Rose; J J Cebra
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

Review 10.  Enteric immunization reveals a T cell network for IgA responses and suggests that humans possess a common mucosal immune system.

Authors:  J R McGhee; H Kiyono; S M Michalek; J Mestecky
Journal:  Antonie Van Leeuwenhoek       Date:  1987       Impact factor: 2.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.